Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
Novo Nordisk (NVO) shares are lower as it disappointed investors hoping for concrete turnaround plans from Chief Executive Officer Mike Doustdar after losing its lead in the obesity market to Eli Lilly & Co. The company pledged to launch more than five blockbusters and deliver more than $23 billion in new sales in coming years, but investors are selling shares due to lack of concrete news.
Arhaus (ARHS) is moving after Jefferies upgraded the furniture company to buy from hold, writing that it has “newfound optimism on the retailer’s strategy to elevate brand awareness” and improve market share.
Accenture (ACN) is up on news Anthropic is partnering with Accenture to test the safety of its advanced artificial intelligence models by embedding evaluators from the consulting firm directly within its operations.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Novo Nordisk (NVO) shares are lower as it disappointed investors hoping for concrete turnaround plans from Chief Executive Officer Mike Doustdar after losing its lead in the obesity market to Eli Lilly & Co. The company pledged to launch more than five blockbusters and deliver more than $23 billion in new sales in coming years, but investors are selling shares due to lack of concrete news.
- Critical Metals (CRML) is soaring as President Trump said the he reached an agreement with Denmark over Greenland that would give the US “permanent control over security” of the Arctic island and that this deal addressed US concerns over the territory.
- Warner Bros (WBD) shares are higher as the settlement talks between Paramount Skydance and California officials over the planned acquisition of Warner Bros. Discovery are said to include a financial penalty if the company fails to make good on a promise to distribute 30 films per year in theaters.
- Accenture (ACN) is up on news Anthropic is partnering with Accenture to test the safety of its advanced artificial intelligence models by embedding evaluators from the consulting firm directly within its operations.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Novo Nordisk disappointed investors hoping for more concrete turnaround plans from Chief Executive Officer Mike Doustdar after the Danish drugmaker lost its lead in the booming obesity market to Eli Lilly & Co.
- Societe Generale Chief Executive Officer Slawomir Krupa lifted the lender’s profitability target as he aims to cut costs and boost investor payouts with a new strategy.
- Sazerac said it plans to acquire German schnapps maker Berentzen-Gruppe as the US spirits firm pushes to add brands in Europe, confirming an earlier Bloomberg News report.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Societe Generale Chief Executive Officer Slawomir Krupa lifted the lender’s profitability target as he aims to cut costs and boost investor payouts with a new strategy.
- Kuehne+Nagel shares rise as much as 5.2% following the freight transportation firm’s collaboration with US tech behemoth Amazon, which will include providing assistance on logistics services and infrastructure for Amazon Web Services.
- Lotus Bakeries gains as much as 5.5% after Jefferies initiates coverage of the Biscoff biscuits maker with a buy recommendation, calling the firm “one of Europe’s fastest-growing consumer compounders.”
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Samsung Electronics’ shares climb as much as 4.8%, the most in two weeks, with investors likely turning focus to its dividend record date later this month.
- Oil and military stocks like Hyundai Rotem are being hit as traders grapple with the war in the Middle East
- Chinese pharma stocks extend gains after Beijing released a five-year plan for the industry, with Citigroup saying it broadly supports domestic innovators, including biotech firms, AI-driven drug discovery companies and makers of high-end medical devices.
See omnystudio.com/listener for privacy information.